Drugs / Noribogaine
Noribogaine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06480981 | Jun → Dec 2024 | — | DemeRx NB | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Noribogaine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06480981 ↗ |
| Known as | 12-hydroxyibogamine | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068516 ↗ |
| Known as | Ibogamin-12-ol | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068516 ↗ |
| Known as | J666.099A | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068516 ↗ |
| Known as | O-demethylibogaine | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068516 ↗ |
| Known as | O-noribogaine | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068516 ↗ |
| Modality | Small molecule | — CHEMBL6068516 ↗ |